We are live on
!
Find out more
Nomura Holdings Portfolio holdings
AUM
$37.7B
1-Year Est. Return
34.44%
This Fund
S&P 500
This Quarter
Est. Return
-3.5%
1 Year Est. Return
+34.44%
3 Year Est. Return
+90.26%
5 Year Est. Return
+115.49%
10 Year Est. Return
+595.58%
AUM
$35.2B
AUM Growth
-$1.77B
(-4.8%)
Cap. Flow
-$1.8B
Cap. Flow
% of AUM
-5.12%
Top 10 Holdings %
Top 10 Hldgs %
37.99%
Holding
1,752
New
369
Increased
328
Reduced
365
Closed
390
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$253M |
| 2 |
Meta Platforms (Facebook)
META
|
+$198M |
| 3 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$114M |
| 4 |
Crown Castle
CCI
|
+$105M |
| 5 |
Bausch Health
BHC
|
+$58.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$278M |
| 2 |
Avis
CAR
|
+$272M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$264M |
| 4 |
Crown Holdings
CCK
|
+$214M |
| 5 |
Fidelity National Information Services
FIS
|
+$213M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.3% |
| 2 | Consumer Staples | 3.91% |
| 3 | Healthcare | 3.09% |
| 4 | Communication Services | 2.92% |
| 5 | Consumer Discretionary | 2.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Ecolab
ECL
$79.9B
| $547K | ﹤0.01% |
3,229
-3,082
| -49% | -$561K |
|
1027
Mitek Systems
MITK
$835M
| $547K | ﹤0.01% |
51,000
+28,600
| +128% | +$320K |
|
1028
Stryker
SYK
$130B
| $547K | ﹤0.01% |
2,000
+627
| +46% | +$180K |
|
|
GAP
1029
CALL
The Gap Inc
GAP
$7.37B
| $532K | ﹤0.01% |
50,000
| – | – |
|
|
NVO
1030
Novo Nordisk
NVO
$209B
| $528K | ﹤0.01% |
+5,810
| New | +$512K |
|
|
BPMC
1031
DELISTED
Blueprint Medicines
BPMC
| $527K | ﹤0.01% |
+10,500
| New | +$561K |
|
|
NBP
1032
NovaBridge Biosciences American Depositary Shares
NBP
$202M
| $524K | ﹤0.01% |
397,085
-46,000
| -10% | -$101K |
|
|
RPT.PRD
1033
DELISTED
RPT Realty 7.25% Series D Cumulative Convertible Perpetual Preferred Shares of Beneficial Interest
RPT.PRD
| $521K | ﹤0.01% |
+10,244
| New | +$514K |
|
1034
Medtronic
MDT
$112B
| $516K | ﹤0.01% |
6,591
-456,281
| -99% | -$38.2M |
|
1035
Chubb
CB
$135B
| $512K | ﹤0.01% |
2,461
-3,612
| -59% | -$730K |
|
1036
Fortinet
FTNT
$117B
| $510K | ﹤0.01% |
+8,692
| New | +$575K |
|
1037
Novartis
NVS
$297B
| $509K | ﹤0.01% |
+5,000
| New | +$508K |
|
1038
MINISO
MNSO
$3.75B
| $508K | ﹤0.01% |
19,615
-3,300
| -14% | -$73.5K |
|
|
LTHM
1039
CALL
DELISTED
Livent Corporation
LTHM
| $506K | ﹤0.01% |
27,500
| – | – |
|
1040
EPAM Systems
EPAM
$5.09B
| $503K | ﹤0.01% |
1,967
-13,040
| -87% | -$3.22M |
|
1041
Vishay Intertechnology
VSH
$5.43B
| $502K | ﹤0.01% |
20,290
+9,280
| +84% | +$250K |
|
1042
FirstEnergy
FE
$27.5B
| $499K | ﹤0.01% |
14,596
-3,658
| -20% | -$136K |
|
|
NOAH
1043
Noah Holdings
NOAH
$603M
| $498K | ﹤0.01% |
39,900
| – | – |
|
1044
Global Partners
GLP
$1.7B
| $494K | ﹤0.01% |
+14,000
| New | +$449K |
|
1045
PUT
Regeneron Pharmaceuticals
REGN
$80.8B
| $494K | ﹤0.01% |
600
-3,000
| -83% | -$2.36M |
|
1046
Philip Morris
PM
$295B
| $480K | ﹤0.01% |
5,190
-1,955
| -27% | -$188K |
|
1047
Murphy USA
MUSA
$9.61B
| $478K | ﹤0.01% |
+1,400
| New | +$445K |
|
1048
CALL
Teck Resources
TECK
$32.6B
| $478K | ﹤0.01% |
11,100
-839,500
| -99% | -$34.8M |
|
1049
Shift4
FOUR
$3.27B
| $467K | ﹤0.01% |
8,436
+298
| +4% | +$18.2K |
|
1050
Valero Energy
VLO
$85.9B
| $463K | ﹤0.01% |
3,267
-3,192
| -49% | -$418K |
|
Similar funds
Nomura Holdings's Q3 2023 Portfolio in Review
As of Q3 2023, Nomura Holdings held 1,752 positions worth $35.2B, down 4.8% from $37B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Nomura Holdings withdrew a net $1.8B in Q3 2023, closing 390 positions and reducing 365 holdings. Its most notable exit was Match Group, an estimated $278M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 5% a quarter earlier, followed by Consumer Staples and Healthcare.
Against the trend, Nomura Holdings opened a new position in BioMarin Pharmaceuticals worth $251M.
- Nomura Holdings's largest Q3 2023 buy was BioMarin Pharmaceuticals: 2,840,810 shares worth $251M.
- Nomura Holdings added most to Meta Platforms (Facebook) in Q3 2023, an estimated $198M increase.
- Nomura Holdings's biggest Q3 2023 reduction was Avis, cutting an estimated $272M.
- Nomura Holdings fully exited Match Group in Q3 2023, selling an estimated $278M.
- Nomura Holdings's ten largest holdings make up 38% of its $35.2B portfolio in Q3 2023.
- Nomura Holdings opened 369 new positions and closed 390 in Q3 2023.
- Nomura Holdings's portfolio value fell 4.8% quarter-over-quarter to $35.2B.
Based on Nomura Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.